AU2018212530B2 - Fecal microbiota for treating patients undergoing a hematopoietic stem cell transplant - Google Patents

Fecal microbiota for treating patients undergoing a hematopoietic stem cell transplant Download PDF

Info

Publication number
AU2018212530B2
AU2018212530B2 AU2018212530A AU2018212530A AU2018212530B2 AU 2018212530 B2 AU2018212530 B2 AU 2018212530B2 AU 2018212530 A AU2018212530 A AU 2018212530A AU 2018212530 A AU2018212530 A AU 2018212530A AU 2018212530 B2 AU2018212530 B2 AU 2018212530B2
Authority
AU
Australia
Prior art keywords
sample
fecal microbiota
transplant
hsc
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018212530A
Other languages
English (en)
Other versions
AU2018212530A1 (en
Inventor
Mohamad Mohty
Harry SOKOL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé et de la Recherche Médicale
Sorbonne Université
Original Assignee
Centre National de la Recherche Scientifique
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé et de la Recherche Médicale
Sorbonne Université
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59325347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2018212530(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centre National de la Recherche Scientifique, Assistance Publique - Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université filed Critical Centre National de la Recherche Scientifique
Publication of AU2018212530A1 publication Critical patent/AU2018212530A1/en
Application granted granted Critical
Publication of AU2018212530B2 publication Critical patent/AU2018212530B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2018212530A 2017-01-26 2018-01-26 Fecal microbiota for treating patients undergoing a hematopoietic stem cell transplant Active AU2018212530B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1750629 2017-01-26
FR1750629A FR3062063B1 (fr) 2017-01-26 2017-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
PCT/EP2018/051941 WO2018138251A1 (fr) 2017-01-26 2018-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques

Publications (2)

Publication Number Publication Date
AU2018212530A1 AU2018212530A1 (en) 2019-09-05
AU2018212530B2 true AU2018212530B2 (en) 2022-06-23

Family

ID=59325347

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018212530A Active AU2018212530B2 (en) 2017-01-26 2018-01-26 Fecal microbiota for treating patients undergoing a hematopoietic stem cell transplant

Country Status (20)

Country Link
US (1) US20200188450A1 (enExample)
EP (1) EP3573631B1 (enExample)
JP (1) JP7527109B2 (enExample)
KR (1) KR102517287B1 (enExample)
CN (1) CN110520141A (enExample)
AU (1) AU2018212530B2 (enExample)
CA (1) CA3051807C (enExample)
DK (1) DK3573631T3 (enExample)
ES (1) ES2937965T3 (enExample)
FI (1) FI3573631T3 (enExample)
FR (1) FR3062063B1 (enExample)
HR (1) HRP20230122T1 (enExample)
HU (1) HUE061155T2 (enExample)
IL (1) IL268237B (enExample)
LT (1) LT3573631T (enExample)
PL (1) PL3573631T3 (enExample)
PT (1) PT3573631T (enExample)
RS (1) RS63978B1 (enExample)
SI (1) SI3573631T1 (enExample)
WO (1) WO2018138251A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200038506A (ko) * 2017-08-07 2020-04-13 핀치 테라퓨틱스, 인코포레이티드 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법
US20220023419A1 (en) * 2018-11-28 2022-01-27 The Council Of The Queensland Institute Of Medical Research Inhibiting inflammation
CN112375705A (zh) * 2020-11-12 2021-02-19 安徽燕婉健康科技有限公司 一种替代天然菌群的肠壁移植优势菌的制备方法及其应用
EP4386090A1 (en) * 2022-12-12 2024-06-19 Assistance Publique - Hôpitaux De Paris Method for determining and improving the potential efficacy of anticancer treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649719B1 (fr) * 1989-07-17 1993-08-27 Cerbio Sa Procede de protection et de conservation de micro-organismes notamment de bacteries
BR112013022927A2 (pt) * 2011-03-09 2016-12-06 Univ Minnesota composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
CN104918624A (zh) * 2012-11-26 2015-09-16 托马斯·朱利叶斯·波洛迪 恢复排泄物微生物群的组合物及其制造和使用方法
WO2016057671A1 (en) * 2014-10-07 2016-04-14 University Of Virginia Patent Foundation Compositions and methods for preventing and treating infection
ES3010296T3 (en) * 2014-11-25 2025-04-02 Memorial Sloan Kettering Cancer Center Intestinal microbiota and gvhd
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
FR3035328B1 (fr) * 2015-04-24 2019-08-23 Maat Pharma Procede de preparation d'un echantillon de microbiote fecal
US20180185421A1 (en) * 2016-08-29 2018-07-05 Tokyo Metropolitan Government Composition comprising fecal microbiota

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
D ZAMA, E BIAGI, R MASETTI, P GASPERINI, A PRETE, M CANDELA, P BRIGIDI, A PESSION: "Gut microbiota and hematopoietic stem cell transplantation: where do we stand?", BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, GB, vol. 52, no. 1, 1 January 2017 (2017-01-01), GB , pages 7 - 14, XP055416106, ISSN: 0268-3369, DOI: 10.1038/bmt.2016.173 *
KAKIHANA, ET AL: "Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut", BLOOD, vol. 128, no. 16, 20 October 2016 (2016-10-20), pages 2083 - 2088, XP055402621, DOI: 10.1182/blood-2016-05-717652 *
LOEBE: "Texas Heart Institute Journal", 1 January 2011 (2011-01-01), XP055416663, Retrieved from the Internet [retrieved on 20171018] *

Also Published As

Publication number Publication date
KR102517287B1 (ko) 2023-03-31
PL3573631T3 (pl) 2023-05-02
RS63978B1 (sr) 2023-03-31
IL268237A (en) 2019-09-26
AU2018212530A1 (en) 2019-09-05
EP3573631A1 (fr) 2019-12-04
SI3573631T1 (sl) 2023-09-29
US20200188450A1 (en) 2020-06-18
CN110520141A (zh) 2019-11-29
PT3573631T (pt) 2023-01-24
ES2937965T3 (es) 2023-04-03
FR3062063B1 (fr) 2019-04-19
CA3051807A1 (fr) 2018-08-02
FI3573631T3 (fi) 2023-03-02
JP7527109B2 (ja) 2024-08-02
KR20190130563A (ko) 2019-11-22
FR3062063A1 (fr) 2018-07-27
HUE061155T2 (hu) 2023-05-28
JP2020506183A (ja) 2020-02-27
WO2018138251A1 (fr) 2018-08-02
HRP20230122T1 (hr) 2023-03-31
CA3051807C (fr) 2023-07-11
IL268237B (en) 2022-07-01
EP3573631B1 (fr) 2022-11-16
LT3573631T (lt) 2023-03-10
DK3573631T3 (da) 2023-01-30

Similar Documents

Publication Publication Date Title
JP6858747B2 (ja) 便微生物試料を調製する方法
KR102517287B1 (ko) 조혈 줄기 세포 이식을 받는 환자를 치료하기 위한 분변 미생물총
AU2019229721A1 (en) Stool collection method and sample preparation method for transplanting fecal microbiota
US20200038459A1 (en) Composition comprising fecal microbiota
JP2020526583A5 (enExample)
Speck et al. Allogeneic marrow transplantation for chronic granulocytic leukemia
Van Bekkum et al. The effect of pretreatment of allogeneic bone marrow graft recipients with antilymphocytic serum on the acute graft-versus-host reaction in monkeys
Daniluk et al. Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract
Zhang et al. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia.
CN114164112A (zh) 一种微生物保护组合物及其制备方法和应用
JP2010509360A (ja) 幹細胞移植を補助するためにＡＬＤＨｂｒ細胞を使用する方法
Sinitsyn et al. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization
EP1881838B1 (en) Antitumor agent on the base of bcg vaccine, method for its preparation and its use
KR20240115760A (ko) 가세리를 포함하는 면역조절 유도 조성물
Schneiderman et al. 222: Donor Chimerism Kinetics in Pediatric Patients Undergoing Reduced Intensity Conditioning (RIC) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Kennedy-Nasser et al. 223: Alternative Donor Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia Using Campath in a Myeloablative Conditioning Regimen
WO2023056075A1 (en) Compositions and methods for reduced toxicity in transplantation using janus kinase (jak) inhibitors
e FAMILY et al. Disease free survival in paediatric malignant disorders with cost effective care after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single centre experience from south India
Sung et al. Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center
WO2021026195A1 (en) Autologous thymic tissue transplantation
Alvaro et al. Leak Treatment in Pancreas Transplant: 753
Wingard Past, Present, Future
Grochowiecki et al. The Timing and a Cause of the Graft Pancreatectomy Has an Impact on the Simultaneous Pancreas and Kidney Recipient Survival: 449
Ghavamzadeh et al. Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
Bonfim et al. Allogeneic stem cell transplantation for the treatment of 12 patients with paroxysmal nocturnal hemoglobinuria in Brazil

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
GD Licence registered

Name of requester: MAAT PHARMA